11-17521006-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_153676.4(USH1C):​c.1086-12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0502 in 1,613,244 control chromosomes in the GnomAD database, including 3,089 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 909 hom., cov: 31)
Exomes 𝑓: 0.046 ( 2180 hom. )

Consequence

USH1C
NM_153676.4 intron

Scores

2
Splicing: ADA: 0.00004067
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.118

Publications

10 publications found
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
USH1C Gene-Disease associations (from GenCC):
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia
  • autosomal recessive nonsyndromic hearing loss 18A
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 11-17521006-C-T is Benign according to our data. Variant chr11-17521006-C-T is described in ClinVar as Benign. ClinVar VariationId is 47974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1CNM_153676.4 linkc.1086-12G>A intron_variant Intron 13 of 26 ENST00000005226.12 NP_710142.1
USH1CNM_005709.4 linkc.1086-12G>A intron_variant Intron 13 of 20 ENST00000318024.9 NP_005700.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1CENST00000005226.12 linkc.1086-12G>A intron_variant Intron 13 of 26 5 NM_153676.4 ENSP00000005226.7
USH1CENST00000318024.9 linkc.1086-12G>A intron_variant Intron 13 of 20 1 NM_005709.4 ENSP00000317018.4

Frequencies

GnomAD3 genomes
AF:
0.0861
AC:
13084
AN:
152014
Hom.:
897
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0881
Gnomad ASJ
AF:
0.0859
Gnomad EAS
AF:
0.0316
Gnomad SAS
AF:
0.0208
Gnomad FIN
AF:
0.0364
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0402
Gnomad OTH
AF:
0.0852
GnomAD2 exomes
AF:
0.0603
AC:
15159
AN:
251444
AF XY:
0.0550
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.104
Gnomad ASJ exome
AF:
0.0919
Gnomad EAS exome
AF:
0.0313
Gnomad FIN exome
AF:
0.0369
Gnomad NFE exome
AF:
0.0434
Gnomad OTH exome
AF:
0.0634
GnomAD4 exome
AF:
0.0465
AC:
67897
AN:
1461112
Hom.:
2180
Cov.:
47
AF XY:
0.0454
AC XY:
33004
AN XY:
726884
show subpopulations
African (AFR)
AF:
0.196
AC:
6564
AN:
33432
American (AMR)
AF:
0.101
AC:
4534
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0869
AC:
2270
AN:
26132
East Asian (EAS)
AF:
0.0364
AC:
1445
AN:
39694
South Asian (SAS)
AF:
0.0277
AC:
2393
AN:
86252
European-Finnish (FIN)
AF:
0.0404
AC:
2153
AN:
53350
Middle Eastern (MID)
AF:
0.0807
AC:
465
AN:
5764
European-Non Finnish (NFE)
AF:
0.0402
AC:
44651
AN:
1111392
Other (OTH)
AF:
0.0567
AC:
3422
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
3295
6590
9885
13180
16475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1804
3608
5412
7216
9020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0864
AC:
13138
AN:
152132
Hom.:
909
Cov.:
31
AF XY:
0.0843
AC XY:
6271
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.191
AC:
7910
AN:
41452
American (AMR)
AF:
0.0881
AC:
1346
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0859
AC:
298
AN:
3470
East Asian (EAS)
AF:
0.0316
AC:
164
AN:
5182
South Asian (SAS)
AF:
0.0206
AC:
99
AN:
4814
European-Finnish (FIN)
AF:
0.0364
AC:
386
AN:
10608
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0402
AC:
2733
AN:
68006
Other (OTH)
AF:
0.0844
AC:
178
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
550
1099
1649
2198
2748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0562
Hom.:
201
Bravo
AF:
0.0964
Asia WGS
AF:
0.0420
AC:
144
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 24, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 30, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 1C Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive nonsyndromic hearing loss 18A Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
11
DANN
Benign
0.77
PhyloP100
0.12
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000041
dbscSNV1_RF
Benign
0.060
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11024318; hg19: chr11-17542553; COSMIC: COSV107202986; COSMIC: COSV107202986; API